About
Biologics
Areas of Focus
Categories
Biologics & BiopharmaceuticalAntibodyNorth & South Carolina
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
0
As Collaborator
2
Total Enrollment
48
By Phase
PHASE2: 2
By Status
NOT_YET_RECRUITING: 1TERMINATED: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
Today
Hover over trial bars to see details
Recent Trials
NCT07103746Collaborator
Ublituximab in Autoantibody Positive Immune Mediated Necrotizing Myopathy
PHASE2Not yet recruiting
30 participants
Started: Nov 30, 2025 · Completed: Jun 30, 2030
NCT03919175Collaborator
Umbralisib and Rituximab as Initial Therapy for Patients With Follicular Lymphoma and Marginal Zone Lymphoma
PHASE2Terminated
18 participants
Started: Sep 1, 2019 · Completed: May 5, 2024
Locations (1)
Headquarters
Morrisville, NC, United States
Map
Loading map...